SCHEMBL20205375

SCHEMBL20205375

CC1(C)c2cc3c(cc2-c2c1cc(-c1ccc(-c4cccc5ccccc45)cc1)c1oc4ccccc4c21)C(C)(C)c1cc(-c2ccc(-c4cccc5ccccc45)cc2)c2oc4ccccc4c2c1-3

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ENPP3 O14638 1/20 0.36
▸ ENPP1 P22413 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ PPARG P37231 7/20 0.34
▸ PPARA Q07869 7/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ PPARD Q03181 1/20 0.34
▸ MCL1 Q07820 1/20 0.34
▸ ACMSD Q8TDX5 1/20 0.34
▸ CA12 O43570 3/20 0.33
▸ CA1 P00915 3/20 0.33
▸ CA2 P00918 3/20 0.33
▸ CA9 Q16790 3/20 0.33
▸ CDC14B O60729 2/20 0.33
▸ CDC14A Q9UNH5 2/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205312 0.96 ENPP3 (0.34) ENPP3ENPP1ALOX5PPARGPPARA
SCHEMBL20205311 0.92 ALOX5 (0.36) ENPP3ENPP1ALOX5PPARGPPARA
SCHEMBL20205469 0.92 MAOA (0.36) ALOX5CYP2C19
SCHEMBL24649901 0.91 ALOX5 (0.36) ENPP3ENPP1ALOX5PPARGPPARA
SCHEMBL20205630 0.91 ALOX5 (0.36) ALOX5CDC14BCDC14A
SCHEMBL20205378 0.89 CDC14B (0.38) ALOX5CA12CA1CA2CA9
SCHEMBL20205335 0.89 CDC14B (0.40) ALOX5MCL1CA12CA1CA2
SCHEMBL20210071 0.88 ENPP3 (0.32) ENPP3ENPP1ALOX5
SCHEMBL24649650 0.88 ALOX5 (0.33) ENPP3ENPP1ALOX5PPARGPPARA
SCHEMBL20205712 0.87 MAOA (0.34) ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND ENPP3 2950/4885ENPP1 2590/4885ALOX5 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback